The social benefits are evident: cost savings for the Health Service and improvement in patient’s quality of life.
Call identifier: H2020-ECSEL-2015-1-RIA
EU Commission 2016-2019
Grant agreement: 692470
“This project has received funding from the Electronic Component Systems for European Leadership Joint Undertaking under grant agreement No 692470. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and Netherlands, Italy, Finland, Czech Republic, Belgium, Spain”.
Astonish will deliver breakthrough imaging and sensing technologies for monitoring, diagnosis and treatment applications by developing smart optical imaging technology that extends the use of minimally invasive diagnosis and treatment and allows for unobtrusive health monitoring. The project will integrate miniaturized optical components, data processing units and SW applications into smart imaging systems that are less obtrusive, cheaper, more reliable and easier to use than state of the art systems. This results into 6 demonstrators by which the technologies will be validated and which allow for pre-clinical testing in the scope of the project.
NorayBio aims to develop new prognosis models and to produce a module for skin cancer detection. We also expect to develop and adapt new mathematical techniques for the development of diagnosis and prognosis algorithms. The new software application for skin cancer detection will increase the company portfolio and our presence in the medical software sector. The knowhow in mathematical techniques for the development of diagnosis algorithms could also be applied to other kinds of diseases.